The Global Abdominal Aortic Aneurysm Repair Devices Market is estimated to be valued at USD 3.12 Bn in 2026 and is expected to reach approximately USD 4.58 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.

The market is experiencing steady growth, mainly driven by the rising prevalence of abdominal aortic aneurysms among the aging population, increasing adoption of minimally invasive endovascular aneurysm repair procedures, expansion of aneurysm screening programs, and continued technological advancements in aortic stent-graft systems.

Abdominal aortic aneurysm repair devices are used to isolate, reinforce, or repair weakened and enlarged sections of the abdominal aorta. The market includes abdominal aortic stent grafts, introducer sheaths, catheters, angioplasty balloons, guidewires, and other procedural accessories used during endovascular and open aneurysm repair procedures.

Healthcare providers are increasingly adopting endovascular aneurysm repair due to its minimally invasive nature, shorter recovery period, reduced hospital stay, and suitability for selected elderly and high-risk patients. Advancements in lower-profile delivery systems, graft conformability, fixation mechanisms, sealing technologies, and modular device designs are also enabling physicians to manage a wider range of vascular anatomies.

The increasing use of fenestrated and branched stent-graft systems is expanding treatment opportunities for patients with anatomically complex aneurysms located near the renal and visceral arteries. In addition, the integration of artificial intelligence, automated CT angiography analysis, and patient-specific procedural planning is improving aneurysm assessment, device sizing, sealing-zone evaluation, and preoperative planning.

Market Dynamics

The Global Abdominal Aortic Aneurysm Repair Devices Market is gaining momentum due to the increasing diagnosis of abdominal aortic aneurysms, expansion of organized screening and surveillance programs, and rising preference for minimally invasive vascular procedures.

Population aging represents one of the major factors influencing market growth. Older adults have a higher risk of developing abdominal aortic aneurysms, thereby increasing the number of patients requiring routine surveillance, vascular-surgeon assessment, and elective or emergency repair procedures.

The growing adoption of endovascular aneurysm repair is supporting demand for abdominal stent grafts and associated procedural devices. Compared with conventional open surgical repair, endovascular procedures can be performed through smaller vascular access points and are increasingly preferred for eligible patients due to reduced procedural trauma and shorter recovery periods.

Technological advancements in stent-graft systems are also accelerating market development. Manufacturers are focusing on lower-profile introducer systems, improved graft flexibility, enhanced sealing performance, better fixation, wider sizing options, and devices designed for short, angulated, narrow, calcified, or tortuous vascular anatomies.

The expansion of hybrid operating rooms, advanced angiographic imaging facilities, vascular-surgery programs, and specialized aortic treatment centers is strengthening institutional demand. Hospitals remain the primary end users because abdominal aortic aneurysm repair requires experienced vascular specialists, advanced imaging systems, anesthesia support, intensive-care facilities, blood-bank access, and emergency open-surgery capabilities.

However, the market faces challenges associated with the high cost of advanced stent-graft systems, risk of endoleaks, graft migration, vascular-access complications, stringent regulatory requirements, and the need for long-term post-procedure surveillance. Some patients may also require secondary interventions following endovascular aneurysm repair.

Continued regulatory oversight and post-approval surveillance are encouraging manufacturers to generate long-term clinical evidence related to device durability, aneurysm enlargement, migration, endoleaks, occlusion, rupture, conversion to open surgery, and aneurysm-related mortality. This is expected to support product-quality improvements and strengthen physician confidence in advanced repair systems.

Key Features of the Study

• This report provides in-depth analysis of the Abdominal Aortic Aneurysm Repair Devices Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Abdominal Aortic Aneurysm Repair Devices Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic Plc., Cardinal Health Inc., Lombard Medical Inc., Endologix, Inc., Cook Group Incorporated, Boston Scientific Corporation, Terumo Corporation, and W. L. Gore & Associates, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Abdominal Aortic Aneurysm Repair Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Abdominal Aortic Aneurysm Repair Devices Market

Market Segmentation

• By Product Type (Revenue, USD Bn, 2021-2033)
  • Stents
  • Sheaths
  • Catheters
  • Balloons
  • Wires
  • Others
• By End User (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Ambulatory Surgical Centers
• By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
• Key Players
  • Medtronic Plc.
  • Cardinal Health Inc.
  • Lombard Medical Inc.
  • Endologix, Inc.
  • Cook Group Incorporated
  • Boston Scientific Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.